Clinical Trials Logo

Ectopic ACTH Syndrome clinical trials

View clinical trials related to Ectopic ACTH Syndrome.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02780882 Withdrawn - Clinical trials for Ectopic ACTH Syndrome

SOM230 Ectopic ACTH-producing Tumors

Start date: December 2015
Phase: Phase 2
Study type: Interventional

The purpose of this prospective open-label phase II study, is to evaluate the efficacy of pasireotide twice daily subcutaneous injections for normalizing 24 hour urine free cortisol in patients with ectopic ACTH-producing tumors as measured by the proportion of patients achieving normal UFC at the end of the study period.